<p>Longitudinal biomarker dynamics of (<b>A</b>) Neurofilament light levels (NFL), (<b>B</b>) YKL-40 and (<b>C</b>) Total Tau (T-tau), and (<b>D</b>) Phospho-tau (P-tau). Each line represents one individual, starting at the first CSF sample and protein concentration, finishing at the time of the second sample and concentration.</p
Huntington’s disease is a severe but slowly progressive hereditary illness for which only symptomati...
Huntington disease (HD) is a fatal neurodegenerative disorder, with no effective treatment. The path...
The current treatment for Alzheimer's disease (AD) is purely symptomatic, but medications interferin...
Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light (NFL) and to...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, caused by a CAG-repea...
INTRODUCTION: Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament ligh...
INTRODUCTION:Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light...
There is an unmet need to reliably and non-invasively monitor disease progression in preclinical Hun...
Objective: Neurofilament light (NfL) protein in blood plasma has been proposed as a prognostic bioma...
Plasma phosphorylated tau at threonine 181 (p-tau181) has been proposed as an easily accessible biom...
OBJECTIVES: Serum neurofilament light protein (NfL) is a promising marker of disease onset and progr...
Abstract Full dynamics of biofluid biomarkers have been unknown in patients with Parkinson’s disease...
INTRODUCTION: Huntington's disease (HD) is a neurodegenerative disorder, but evidence also suggests ...
CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-b, are increasingly...
INTRODUCTION:Huntington's disease (HD) is a neurodegenerative disorder, but evidence also suggests n...
Huntington’s disease is a severe but slowly progressive hereditary illness for which only symptomati...
Huntington disease (HD) is a fatal neurodegenerative disorder, with no effective treatment. The path...
The current treatment for Alzheimer's disease (AD) is purely symptomatic, but medications interferin...
Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light (NFL) and to...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, caused by a CAG-repea...
INTRODUCTION: Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament ligh...
INTRODUCTION:Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light...
There is an unmet need to reliably and non-invasively monitor disease progression in preclinical Hun...
Objective: Neurofilament light (NfL) protein in blood plasma has been proposed as a prognostic bioma...
Plasma phosphorylated tau at threonine 181 (p-tau181) has been proposed as an easily accessible biom...
OBJECTIVES: Serum neurofilament light protein (NfL) is a promising marker of disease onset and progr...
Abstract Full dynamics of biofluid biomarkers have been unknown in patients with Parkinson’s disease...
INTRODUCTION: Huntington's disease (HD) is a neurodegenerative disorder, but evidence also suggests ...
CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-b, are increasingly...
INTRODUCTION:Huntington's disease (HD) is a neurodegenerative disorder, but evidence also suggests n...
Huntington’s disease is a severe but slowly progressive hereditary illness for which only symptomati...
Huntington disease (HD) is a fatal neurodegenerative disorder, with no effective treatment. The path...
The current treatment for Alzheimer's disease (AD) is purely symptomatic, but medications interferin...